Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

27.51 -0.16 (-0.58%)

Delayed Quote Updated: 2:32 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Structure Therapeutics Inc. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 29, 2023

Via Benzinga

Why Is Obesity Focused Structure Therapeutics Stock Trading Higher Today? ↗

September 29, 2023

Structure Therapeutics Inc (NASDAQ: GPCR) released results from the Phase 1b multiple ascending dose (MAD) study of GSBR-1290 in healthy, overweight, or

Via Benzinga

Structure Therapeutics Announces $300 Million Private Placement Equity Financing

September 29, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update

September 29, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights

August 10, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗

August 08, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...

Via Benzinga

Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors

August 03, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023 ↗

July 27, 2023

Via Benzinga

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly? ↗

July 13, 2023

An overweight world is hungry for new treatments. For now, two companies own the market.

Via Investor's Business Daily

Why Shares of Structure Therapeutics Rose Monday ↗

June 26, 2023

The company's lead diabetes and weight-loss therapy may benefit from a decision by Pfizer.

Via The Motley Fool

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗

June 26, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Cava Stock Makes A Stand In Mixed IPO Landscape: Where Does It Rank Against Other 2023 Wall Street Debuts? ↗

June 16, 2023

In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterranean restaurant chain Cava Group (NYSE: CAVA) made a striking first public appearance on the New York...

Via Benzinga

This Biotech Is Developing The Next Ozempic. Should You Buy It? ↗

June 16, 2023

If it succeeds, it'll still face a battle for market share.

Via The Motley Fool

Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years ↗

June 12, 2023

If you can tolerate the risk and have some patience, both stocks could blossom.

Via The Motley Fool

Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions

June 07, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics to Present at Jefferies Healthcare Conference

May 31, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday ↗

May 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

May 25, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference

May 18, 2023

Posters include data across biomarker, translation and clinical studies supporting development of cardiopulmonary programs LTSE-2578 and ANPA-0073

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

May 11, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

March 30, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race ↗

February 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗

February 28, 2023

Via Benzinga

There's a Lot to Love About Mineralys' Valentine's Day IPO

February 13, 2023

MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million

Via MarketBeat

Topics Initial Public Offering

Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

February 07, 2023

From Structure Therapeutics Inc.

Via GlobeNewswire

Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development ↗

February 04, 2023

Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...

Via Talk Markets

Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January ↗

February 03, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.51% to 33,881.69 while the NASDAQ fell 1.32% to 12,039.79. The S&P 500 also fell, dropping, 0.98%...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.